A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.

about

Role of inflammatory cells in airway remodeling in COPD

P2860

Q57815421-F7D06154-2142-4BEB-A6A7-DDEC63144638

P2860

A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.

Item

http://www.wikidata.org/entity/Q41336850

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A randomised, placebo-controll ...... obstructive pulmonary disease.

@en

type

Item

label

A randomised, placebo-controll ...... obstructive pulmonary disease.

@en

prefLabel

A randomised, placebo-controll ...... obstructive pulmonary disease.

@en

P1476

A randomised, placebo-controll ...... obstructive pulmonary disease.

@en

P2093

Christine K Ward

http://www.w3.org/2001/XMLSchema#string

Donna K Finch

http://www.w3.org/2001/XMLSchema#string

Mark Penney

http://www.w3.org/2001/XMLSchema#string

Michelle Dawson

http://www.w3.org/2001/XMLSchema#string

Paul Newbold

http://www.w3.org/2001/XMLSchema#string

Peter M A Calverley

http://www.w3.org/2001/XMLSchema#string

René van der Merwe

http://www.w3.org/2001/XMLSchema#string

Sanjay Sethi

http://www.w3.org/2001/XMLSchema#string

P2860

Canakinumab

IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice

Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Cytokine inhibition in the treatment of COPD.

Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease.

How to approach neutropenia.

A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis

P2888

s12931-017-0633-7

P304

153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-017-0633-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091133348

http://www.w3.org/2001/XMLSchema#string

P698

28793896

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

placebo

P932

5551010

http://www.w3.org/2001/XMLSchema#string

A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.

about

P2860

P2860

A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932